Get started Log in

BEAM — Beam Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
$2.55bn
Enterprise Value
$1.50bn
Revenue
$139.74m

Brief: Beam Therapeutics Q3 EPS USD -1.22
08/11/2023 11:31
Beam Therapeutics Inc expected to post a loss of $1.36 a share - Earnings Preview
03/11/2023 13:28
U.S. STOCKS ON THE MOVE-Leidos, EcoLab, Shutterstock
31/10/2023 17:51
U.S. STOCKS ON THE MOVE-GE HealthCare, Pfizer, Ford Motor
31/10/2023 15:59
U.S. STOCKS ON THE MOVE-Monolithic Power Systems, Global Payments, Beam
31/10/2023 13:27
Beam climbs on Lilly deal for opt-in rights to gene-editing program
31/10/2023 12:40
Brief: Verve Therapeutics And Lilly Relationship Expands To Include Verve's In Vivo Gene Editing Programs Targeting PCSK9 And ANGPTL3
31/10/2023 10:33
Brief: Beam Announces Agreement For Lilly To Acquire Beam’S Opt-In Rights To Verve Therapeutics’ Base Editing Programs
31/10/2023 10:24
Brokerage cuts Beam Therapeutics rating, PT on cash runway concerns
20/10/2023 12:14
U.S. RESEARCH ROUNDUP- Ares Management, Murphy USA, Tesla
20/10/2023 08:04
U.S. STOCKS ON THE MOVE-American Airlines, Netflix, Tesla
19/10/2023 17:19
Beam Therapeutics plans to cut 20% of workforce; shares fall
19/10/2023 15:21
Brief: Beam Therapeutics To Cut 20% Workforce
19/10/2023 14:45
Beam Therapeutics to cut 20% of workforce as part of restructuring plan (updated)
19/10/2023 14:03
Beam Therapeutics to cut 20% of workforce
19/10/2023 13:54
Brief: Beam Therapeutics Inc - Plans To Submit A Regulatory Application For Authorization To Initiate Clinical Trials Of Beam-302 In Q1 Of 2024
07/09/2023 16:50
Brief: Beam Therapeutics Announces First Patient Dosed In Phase 1/2 Trial Of BEAM-201 In Relapsed, Refractory T-ALL/T-LL
05/09/2023 11:41
U.S. RESEARCH ROUNDUP-Dollar Tree, Hexcel, Humacyte
15/08/2023 08:18
U.S. RESEARCH ROUNDUP-Celanese, Draftkings, Sovos Brands
09/08/2023 08:38
Beam Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
08/08/2023 13:07